Evidence map›Paper›PMID 40371694›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

MRS demonstrates elevated brain glutathione in vascular mild cognitive impairment compared to cognitively normal coronary artery disease controls.

Jinghan Jenny Chen, Yejin Kang, Damien Gallagher, Nathan Herrmann, Kate Survilla, Danielle Vieira, Ethan Mah, Simon J Graham, Alex Kiss, Sandra E Black and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Construction of an AgMikrochimica acta · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jinghan Jenny ChenHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Yejin KangHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Damien GallagherHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Nathan HerrmannHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Kate SurvillaHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Danielle VieiraHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Ethan MahHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Simon J GrahamHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Alex KissDepartment of Research Design and Biostatistics, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Sandra E BlackHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Joel RamirezHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Paul OhKITE Toronto Rehabilitation Institute, Toronto Rehabilitation Institute-University Health Network, Toronto, Ontario, Canada.
Susan MarzoliniKITE Toronto Rehabilitation Institute, Toronto Rehabilitation Institute-University Health Network, Toronto, Ontario, Canada.
Katherine A ZukotynskiHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Phillip H KuoDepartment of Radiology, City of Hope National Medical Center, Duarte, California, USA.
Krista L LanctôtHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID 0000-0001-7024-6637

Funding

Alzheimer's Association PTC-18-543823Alzheimer Society Research Program ASRP #21-11CIHR MOP201803PJ8
6 · The paper itself

Abstract

introductionOxidative stress (OS) is implicated in dementia. While elevated peripheral OS biomarkers were observed in vascular mild cognitive impairment (vMCI), the role of central antioxidants remains unclear. We assessed levels of the major brain antioxidant glutathione (GSH) in vMCI compared to cognitively normal coronary artery disease (CAD) controls (CN).

methodsIn vivo tissue-corrected GSH in the anterior cingulate cortex (ACC) and occipital cortex (OC) were quantified in persons with vMCI and CN using MEscher-GArwood Point RESolved magnetic resonance Spectroscopy.

resultsAmong participants (vMCI, n = 22, age [mean ± SD] = 67.4 ± 7.3; CN, n = 21, age = 66.7 ± 7.8), ACC-GSH (i.u. ± SD) was higher in vMCI (4.42 ± 0.59) versus CN (3.72 ± 1.01) (Z = -2.5, p = .01), even after controlling for age and sex (B [SE] = 0.74 [0.26], p = .007). Increased ACC-GSH correlated with poorer executive function (EF) (B [SE] = -0.31 [0.14], p = .04). OC-GSH showed no effect. DISCUSSION: Higher ACC-GSH in vMCI may reflect a compensatory response to OS. ACC-GSH was negatively correlated with EF, suggesting a linkage between regional brain antioxidants and disease-relevant cognitive domains. HIGHLIGHTS: Brain GSH was measured in vascular MCI and matched controls using MEGA-PRESS. In contrast to GSH deficits in AD, anterior cingulate GSH was elevated in vMCI. Brain GSH was correlated with disease-relevant cognitive domains in vMCI. The GSH antioxidant system may be etiologically implicated in vMCI.

Indexed as

BrainCognitive DysfunctionCoronary Artery DiseaseGlutathioneAgedFemaleGyrus CinguliHumansMagnetic Resonance SpectroscopyMaleMiddle AgedOxidative StressGlutathioneantioxidantbrain biomarkerglutathioneMEGA‐PRESSmild cognitive impairmentvascular cognitive impairment

Identifiers

PMID40371694
PMCPMC12079349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.